L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.58 USD -0.63% Market Closed
Market Cap: 132.2m USD

Intrinsic Value

LUCD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one LUCD stock under the Base Case scenario is 2.07 USD. Compared to the current market price of 1.58 USD, Lucid Diagnostics Inc is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LUCD Intrinsic Value
2.07 USD
Undervaluation 24%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Lucid Diagnostics Inc

LUCD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LUCD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Lucid Diagnostics Inc
NASDAQ:LUCD
US
Health Care
Market Cap
132.2m USD
IPO
Oct 14, 2021
US
Health Care
Market Cap
132.2m USD
IPO
Oct 14, 2021
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LUCD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Lucid Diagnostics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lucid Diagnostics Inc

Current Assets 25.1m
Cash & Short-Term Investments 22.4m
Receivables 45k
Other Current Assets 2.7m
Non-Current Assets 5.6m
PP&E 3.7m
Intangibles 736k
Other Non-Current Assets 1.1m
Efficiency

Free Cash Flow Analysis
Lucid Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lucid Diagnostics Inc

Revenue
4.3m USD
Cost of Revenue
-7.1m USD
Gross Profit
-2.8m USD
Operating Expenses
-43.3m USD
Operating Income
-46.1m USD
Other Expenses
-7m USD
Net Income
-53m USD
Fundamental Scores

LUCD Profitability Score
Profitability Due Diligence

Lucid Diagnostics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
21/100
Profitability
Score

Lucid Diagnostics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

LUCD Solvency Score
Solvency Due Diligence

Lucid Diagnostics Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
High D/E
37/100
Solvency
Score

Lucid Diagnostics Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LUCD Price Targets Summary
Lucid Diagnostics Inc

Wall Street analysts forecast LUCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LUCD is 4.08 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.

Lowest
Price Target
2.02 USD
28% Upside
Average
Price Target
4.08 USD
158% Upside
Highest
Price Target
7.35 USD
365% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lucid Diagnostics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LUCD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LUCD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LUCD stock?

The intrinsic value of one LUCD stock under the Base Case scenario is 2.07 USD.

Is LUCD stock undervalued or overvalued?

Compared to the current market price of 1.58 USD, Lucid Diagnostics Inc is Undervalued by 24%.

Back to Top